New Assay Predicts Cardio Events at Low Troponin T (CME/CE)

Even at levels of the cardiac biomarker too low to be detectable on the standard test, a new assay was able to distinguish risk of cardiovascular events in patients with stable coronary artery disease, researchers found.

source : www.medpagetoday.com

Related News:

• SSRI and Tamoxifen Increase Mortality Risk (CME/CE)
• AAPM: Capsaicin Patch Unaffected by Anesthestics (CME/CE)
• AAPM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
• AAPM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
• HRT Linked to Asthma Risk (CME/CE)
• AM: Facet Graft Quells Refractory Back Pain (CME/CE)
• AM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
• AM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
• AM: Drug for Fibromyalgia Boosts Multiple Outcomes (CME/CE)
• AM: Help for Pain and Mood in Fibromyalgia (CME/CE)

Details :
Submited at Wednesday, November 25th, 2009 at 7:00 pm on Cardiology by robert
Comment RSS 2.0 - leave a comment - trackback